ALBERTSONS COMPANIES, INC., 10-Q filed on 10/14/2025
Quarterly Report
v3.25.3
Cover Page - shares
6 Months Ended
Sep. 06, 2025
Oct. 10, 2025
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 06, 2025  
Document Transition Report false  
Entity File Number 001-39350  
Entity Registrant Name Albertsons Companies, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 47-4376911  
Entity Address, Address Line One 250 Parkcenter Blvd.  
Entity Address, City or Town Boise  
Entity Address, State or Province ID  
Entity Address, Postal Zip Code 83706  
City Area Code 208  
Local Phone Number 395-6200  
Title of 12(b) Security Class A common stock, $0.01 par value  
Trading Symbol ACI  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   549,307,530
Entity Central Index Key 0001646972  
Current Fiscal Year End --02-28  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q2  
Amendment Flag false  
v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 06, 2025
Feb. 22, 2025
Current assets    
Cash and cash equivalents $ 270.6 $ 293.6
Receivables, net 968.8 834.8
Inventories, net 5,187.5 4,989.0
Other current assets 425.7 441.6
Total current assets 6,852.6 6,559.0
Property and equipment, net 9,706.7 9,811.0
Operating lease right-of-use assets 6,132.2 6,153.4
Intangible assets, net 2,251.1 2,318.0
Goodwill 1,201.0 1,201.0
Other assets 706.9 713.3
TOTAL ASSETS 26,850.5 26,755.7
Current liabilities    
Accounts payable 3,987.9 4,092.7
Accrued salaries and wages 1,406.8 1,345.2
Current maturities of long-term debt and finance lease obligations 1,186.4 57.6
Current operating lease obligations 730.3 705.5
Other current liabilities 1,105.3 1,050.0
Total current liabilities 8,416.7 7,251.0
Long-term debt and finance lease obligations 6,940.1 7,762.5
Long-term operating lease obligations 5,710.3 5,657.2
Deferred income taxes 847.0 824.1
Other long-term liabilities 1,856.9 1,875.0
Commitments and contingencies
STOCKHOLDERS' EQUITY    
Additional paid-in capital 2,207.1 2,184.0
Treasury stock, at cost, 48,270,935 and 22,522,934 shares held as of September 6, 2025 and February 22, 2025, respectively (936.8) (386.7)
Accumulated other comprehensive income 82.2 94.7
Retained earnings 1,721.0 1,487.9
Total stockholders' equity 3,079.5 3,385.9
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 26,850.5 26,755.7
Class A common stock    
STOCKHOLDERS' EQUITY    
Class A common stock, $0.01 par value; 1,000,000,000 shares authorized, 600,483,142 and 597,964,926 shares issued as of September 6, 2025 and February 22, 2025, respectively $ 6.0 $ 6.0
v3.25.3
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Sep. 06, 2025
Feb. 22, 2025
Treasury stock, at cost (in shares) 48,270,935 22,522,934
Class A common stock    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 1,000,000,000 1,000,000,000
Common stock shares issued (in shares) 600,483,142 597,964,926
v3.25.3
Condensed Consolidated Statements of Operations and Comprehensive Income - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Sep. 06, 2025
Sep. 07, 2024
Sep. 06, 2025
Sep. 07, 2024
Income Statement [Abstract]        
Net sales and other revenue $ 18,915.8 $ 18,551.5 $ 43,796.6 $ 42,816.9
Cost of sales 13,809.2 13,430.2 31,951.7 30,956.7
Gross margin 5,106.6 5,121.3 11,844.9 11,860.2
Selling and administrative expenses 4,806.9 4,785.4 11,127.8 11,059.4
Loss (gain) on property dispositions and impairment losses, net 4.4 43.9 (27.5) 49.2
Operating income 295.3 292.0 744.6 751.6
Interest expense, net 105.3 103.6 247.1 249.3
Other (income) expense, net (29.7) 1.9 (33.6) 5.9
Income before income taxes 219.7 186.5 531.1 496.4
Income tax expense 51.2 41.0 126.2 110.2
Net income 168.5 145.5 404.9 386.2
Other comprehensive income (loss), net of tax        
Recognition of pension (loss) gain (13.4) 2.9 (14.1) 1.9
Other 1.3 3.0 1.6 2.7
Other comprehensive (loss) income (12.1) 5.9 (12.5) 4.6
Comprehensive income $ 156.4 $ 151.4 $ 392.4 $ 390.8
Net income per Class A common share        
Basic net income per Class A common share (in dollars per share) $ 0.30 $ 0.25 $ 0.71 $ 0.67
Diluted net income per Class A common share (in dollars per share) $ 0.30 $ 0.25 $ 0.71 $ 0.66
Weighted average Class A common shares outstanding        
Basic (in shares) 559.7 580.1 567.3 579.5
Diluted (in shares) 562.5 583.2 569.9 582.4
v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Sep. 06, 2025
Sep. 07, 2024
Cash flows from operating activities:    
Net income $ 404.9 $ 386.2
Adjustments to reconcile net income to net cash provided by operating activities:    
(Gain) loss on property dispositions and impairment losses, net (27.5) 49.2
Depreciation and amortization 1,007.4 973.9
Operating lease right-of-use assets amortization 376.1 364.3
LIFO expense 28.3 19.4
Deferred income tax 26.4 (86.7)
Contributions to pension and post-retirement benefit plans, net of expense (income) (72.7) (29.3)
Deferred financing costs 11.5 8.6
Equity-based compensation expense 52.4 66.2
Other operating activities 14.9 17.0
Changes in operating assets and liabilities:    
Receivables, net (133.7) (174.0)
Inventories, net (226.7) (116.9)
Accounts payable, accrued salaries and wages and other accrued liabilities 110.4 88.5
Operating lease liabilities (285.4) (280.6)
Self-insurance assets and liabilities 2.5 21.2
Other operating assets and liabilities (6.8) 67.1
Net cash provided by operating activities 1,282.0 1,374.1
Cash flows from investing activities:    
Payments for property, equipment and intangibles, including lease buyouts (950.5) (952.3)
Proceeds from sale of assets 82.6 19.8
Other investing activities 30.0 7.2
Net cash used in investing activities (837.9) (925.3)
Cash flows from financing activities:    
Proceeds from issuance of long-term debt, including ABL facility 925.0 50.0
Payments on long-term borrowings, including ABL facility (600.3) (200.4)
Payments of obligations under finance leases (21.9) (26.9)
Payments for debt financing costs (18.1) 0.0
Dividends paid on common stock (169.6) (139.0)
Treasury stock purchase, at cost (550.1) 0.0
Employee tax withholding on vesting of restricted stock units (32.0) (41.5)
Net cash used in financing activities (467.0) (357.8)
Net (decrease) increase in cash and cash equivalents and restricted cash (22.9) 91.0
Cash and cash equivalents and restricted cash at beginning of period 297.9 193.2
Cash and cash equivalents and restricted cash at end of period $ 275.0 $ 284.2
v3.25.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Millions
Total
Common Stock
Additional paid-in capital
Treasury Stock
Accumulated other comprehensive income
Retained earnings
Beginning balance (in shares) at Feb. 24, 2024   594,445,268        
Beginning balance at Feb. 24, 2024 $ 2,747.5 $ 5.9 $ 2,129.6 $ (304.2) $ 88.0 $ 828.2
Beginning balance (in shares) at Feb. 24, 2024       18,397,745    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Equity-based compensation 34.4   34.4      
Shares issued and employee tax withholding on vesting of restricted stock units (in shares)   3,048,974        
Shares issued and employee tax withholding on vesting of restricted stock units (38.5) $ 0.1 (38.6)      
Cash dividends declared on common stock (69.5)         (69.5)
Net income 240.7         240.7
Other comprehensive (loss) income, net of tax (1.3)       (1.3)  
Other activity (in shares)       6,456    
Other activity (0.2)   0.8     (1.0)
Ending balance (in shares) at Jun. 15, 2024   597,494,242        
Ending balance at Jun. 15, 2024 2,913.1 $ 6.0 2,126.2 $ (304.2) 86.7 998.4
Ending balance (in shares) at Jun. 15, 2024       18,404,201    
Beginning balance (in shares) at Feb. 24, 2024   594,445,268        
Beginning balance at Feb. 24, 2024 2,747.5 $ 5.9 2,129.6 $ (304.2) 88.0 828.2
Beginning balance (in shares) at Feb. 24, 2024       18,397,745    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 386.2          
Ending balance (in shares) at Sep. 07, 2024   597,711,686        
Ending balance at Sep. 07, 2024 3,020.3 $ 6.0 2,152.3 $ (304.2) 92.6 1,073.6
Ending balance (in shares) at Sep. 07, 2024       18,404,201    
Beginning balance (in shares) at Jun. 15, 2024   597,494,242        
Beginning balance at Jun. 15, 2024 2,913.1 $ 6.0 2,126.2 $ (304.2) 86.7 998.4
Beginning balance (in shares) at Jun. 15, 2024       18,404,201    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Equity-based compensation 27.9   27.9      
Shares issued and employee tax withholding on vesting of restricted stock units (in shares)   217,444        
Shares issued and employee tax withholding on vesting of restricted stock units (2.9)   (2.9)      
Cash dividends declared on common stock (69.5)         (69.5)
Net income 145.5         145.5
Other comprehensive (loss) income, net of tax 5.9       5.9  
Other activity 0.3   1.1     (0.8)
Ending balance (in shares) at Sep. 07, 2024   597,711,686        
Ending balance at Sep. 07, 2024 3,020.3 $ 6.0 2,152.3 $ (304.2) 92.6 1,073.6
Ending balance (in shares) at Sep. 07, 2024       18,404,201    
Beginning balance (in shares) at Feb. 22, 2025   597,964,926        
Beginning balance at Feb. 22, 2025 $ 3,385.9 $ 6.0 2,184.0 $ (386.7) 94.7 1,487.9
Beginning balance (in shares) at Feb. 22, 2025 22,522,934     22,522,934    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Equity-based compensation $ 34.3   34.3      
Shares issued and employee tax withholding on vesting of restricted stock units (in shares)   2,482,898        
Shares issued and employee tax withholding on vesting of restricted stock units (31.4)   (31.4)      
Repurchase of common stock (in shares)       14,249,535    
Repurchase of common stock (314.8)     $ (314.8)    
Cash dividends declared on common stock (85.7)         (85.7)
Net income 236.4         236.4
Other comprehensive (loss) income, net of tax (0.4)       (0.4)  
Other activity 0.0   1.1     (1.1)
Ending balance (in shares) at Jun. 14, 2025   600,447,824        
Ending balance at Jun. 14, 2025 3,224.3 $ 6.0 2,188.0 $ (701.5) 94.3 1,637.5
Ending balance (in shares) at Jun. 14, 2025       36,772,469    
Beginning balance (in shares) at Feb. 22, 2025   597,964,926        
Beginning balance at Feb. 22, 2025 $ 3,385.9 $ 6.0 2,184.0 $ (386.7) 94.7 1,487.9
Beginning balance (in shares) at Feb. 22, 2025 22,522,934     22,522,934    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 404.9          
Ending balance (in shares) at Sep. 06, 2025   600,483,142        
Ending balance at Sep. 06, 2025 $ 3,079.5 $ 6.0 2,207.1 $ (936.8) 82.2 1,721.0
Ending balance (in shares) at Sep. 06, 2025 48,270,935     48,270,935    
Beginning balance (in shares) at Jun. 14, 2025   600,447,824        
Beginning balance at Jun. 14, 2025 $ 3,224.3 $ 6.0 2,188.0 $ (701.5) 94.3 1,637.5
Beginning balance (in shares) at Jun. 14, 2025       36,772,469    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Equity-based compensation 18.7   18.7      
Shares issued and employee tax withholding on vesting of restricted stock units (in shares)   35,318        
Shares issued and employee tax withholding on vesting of restricted stock units (0.6)   (0.6)      
Repurchase of common stock (in shares)       11,498,466    
Repurchase of common stock (235.3)     $ (235.3)    
Cash dividends declared on common stock (83.9)         (83.9)
Net income 168.5         168.5
Other comprehensive (loss) income, net of tax (12.1)       (12.1)  
Other activity (0.1)   1.0     (1.1)
Ending balance (in shares) at Sep. 06, 2025   600,483,142        
Ending balance at Sep. 06, 2025 $ 3,079.5 $ 6.0 $ 2,207.1 $ (936.8) $ 82.2 $ 1,721.0
Ending balance (in shares) at Sep. 06, 2025 48,270,935     48,270,935    
v3.25.3
Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares
3 Months Ended 4 Months Ended
Sep. 06, 2025
Sep. 07, 2024
Jun. 14, 2025
Jun. 15, 2024
Statement of Stockholders' Equity [Abstract]        
Dividends declared (in dollars per share) $ 0.15 $ 0.12 $ 0.15 $ 0.12
v3.25.3
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Sep. 06, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation

The accompanying interim Condensed Consolidated Financial Statements include the accounts of Albertsons Companies, Inc. and its subsidiaries (the "Company"). All significant intercompany balances and transactions were eliminated. The Condensed Consolidated Balance Sheet as of February 22, 2025 is derived from the Company's annual audited Consolidated Financial Statements, which should be read in conjunction with these Condensed Consolidated Financial Statements and which are included in the Company's Annual Report on Form 10-K for the fiscal year ended February 22, 2025, filed with the Securities and Exchange Commission (the "SEC") on April 21, 2025. Certain information in footnote disclosures normally included in annual financial statements was condensed or omitted for the interim periods presented in accordance with accounting principles generally accepted in the United States of America ("GAAP"). In the opinion of management, the interim data includes all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. The interim results of operations and cash flows are not necessarily indicative of those results and cash flows expected for the year. The Company's results of operations are for the 12 and 28 weeks ended September 6, 2025 and September 7, 2024.

Significant Accounting Policies

Restricted cash: Restricted cash is included in Other current assets or Other assets depending on the remaining term of the restriction and primarily relates to surety bonds. The Company had $4.4 million and $4.3 million of restricted cash as of September 6, 2025 and February 22, 2025, respectively.

Inventories, net: Substantially all of the Company's inventories consist of finished goods valued at the lower of cost or market and net of vendor allowances. The Company primarily uses the retail inventory or cost method to determine inventory cost before application of any last-in, first-out ("LIFO") adjustment. Interim LIFO inventory costs are based on management's estimates of expected year-end inventory levels and inflation rates. The Company recorded LIFO expense of $11.0 million and $4.8 million for the 12 weeks ended September 6, 2025 and September 7, 2024, respectively, and $28.3 million and $19.4 million for the 28 weeks ended September 6, 2025 and September 7, 2024, respectively.

Convertible Common Stock and Preferred Stock: The Company's certificate of incorporation authorizes 150,000,000 shares of Class A-1 convertible common stock, par value $0.01 per share, and 100,000,000 shares of preferred stock, par value $0.01 per share, of which 1,750,000 shares of preferred stock are designated Series A convertible preferred stock and 1,410,000 shares of preferred stock are designated Series A-1 convertible preferred stock. As of September 6, 2025 and February 22, 2025, no shares of Class A-1 convertible common stock and no shares of preferred stock are issued or outstanding.

Common stock repurchase program: On October 14, 2025, subsequent to the end of the 12 weeks ended September 6, 2025, the Company entered into an accelerated share repurchase agreement (the "ASR Agreement") with JPMorgan Chase Bank, National Association to repurchase $750 million of shares of the Company's common stock. Also on October 14, 2025, the Company announced that the Board of Directors has authorized an increase to the share repurchase program from $2.0 billion to $2.75 billion, inclusive of the ASR Agreement.

Income taxes: Income tax expense was $51.2 million for the 12 weeks ended September 6, 2025, representing a 23.3% effective tax rate. The Company's effective tax rate for the 12 weeks ended September 6, 2025 differs from the federal income tax statutory rate of 21% primarily due to state income taxes, partially offset by federal tax credits. Income tax expense was $41.0 million for the 12 weeks ended September 7, 2024, representing a 22.0%
effective tax rate. The Company's effective tax rate for the 12 weeks ended September 7, 2024 differs from the federal income tax statutory rate of 21% primarily due to state income taxes, partially offset by federal tax credits.

Income tax expense was $126.2 million for the 28 weeks ended September 6, 2025, representing a 23.8% effective tax rate. The Company's effective tax rate for the 28 weeks ended September 6, 2025 differs from the federal income tax statutory rate of 21% primarily due to state income taxes, partially offset by federal tax credits. Income tax expense was $110.2 million for the 28 weeks ended September 7, 2024, representing a 22.2% effective tax rate. The Company's effective tax rate for the 28 weeks ended September 7, 2024 differs from the federal income tax statutory rate of 21% primarily due to state income taxes, partially offset by federal tax credits and the reduction of a reserve for an uncertain tax position due to the settlement of a state audit.

On July 4, 2025, the President signed into law An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, commonly referred to as the One Big Beautiful Bill Act (the "Act"), which enacts significant changes to U.S. income tax and related laws. Among other things, the Act makes changes to certain business-related exclusions, deductions and credits. The Company has reflected the impact of the enacted provisions in its financial statements for the second quarter of fiscal 2025, which were determined to be immaterial. While further evaluation is ongoing, the Act is not expected to have a material impact on the Company's financial position or results of operations.

Revenue recognition: Revenues from the retail sale of products are recognized at the point of sale or delivery to the customer, net of returns and sales tax. Pharmacy sales are recorded upon the customer receiving the prescription. Third-party receivables from pharmacy sales were $542.2 million and $464.1 million as of September 6, 2025 and February 22, 2025, respectively, and are recorded in Receivables, net. For digital related sales, which primarily include home delivery and Drive Up & Go curbside pickup, revenues are recognized upon either pickup in store or delivery to the customer and may include revenue for separately charged delivery services. The Company records a contract liability when rewards are earned by customers in connection with the Company's loyalty programs. As rewards are redeemed or expire, the Company reduces the contract liability and recognizes revenue. The contract liability balance was immaterial as of September 6, 2025 and February 22, 2025. Media advertising services are classified as either Net sales and other revenue or a reduction in Cost of sales depending on the nature of the media advertising arrangement.

The Company records a contract liability when it sells its own proprietary gift cards. The Company records a sale when the customer redeems the gift card. The Company's gift cards do not expire. The Company reduces the contract liability and records revenue for the unused portion of gift cards in proportion to its customers' pattern of redemption, which the Company determined to be the historical redemption rate. The Company's contract liability related to gift cards was $105.2 million and $119.9 million as of September 6, 2025 and February 22, 2025, respectively.
Disaggregated Revenues

The following table represents Net sales and other revenue by product type (dollars in millions):
12 weeks ended28 weeks ended
September 6,
2025
September 7,
2024
September 6,
2025
September 7,
2024
Amount (1)% of TotalAmount (1)% of TotalAmount (1)% of TotalAmount (1)% of Total
Non-perishables (2)$9,220.5 48.8 %$9,265.0 49.9 %$21,362.2 48.8 %$21,319.0 49.8 %
Fresh (3)5,946.6 31.4 5,917.4 31.9 13,933.4 31.8 13,822.3 32.3 
Pharmacy2,536.8 13.4 2,132.0 11.5 5,691.8 13.0 4,754.8 11.1 
Fuel911.3 4.8 951.3 5.2 2,141.2 4.9 2,272.2 5.3 
Other (4)300.6 1.6 285.8 1.5 668.0 1.5 648.6 1.5 
Net sales and other revenue$18,915.8 100.0 %$18,551.5 100.0 %$43,796.6 100.0 %$42,816.9 100.0 %
(1) Digital related sales are included in the categories to which the revenue pertains.
(2) Consists primarily of general merchandise, grocery, dairy and frozen foods.
(3) Consists primarily of produce, meat, deli and prepared foods, bakery, floral and seafood.
(4) Consists primarily of wholesale revenue to third parties, commissions, rental income, media advertising revenue and other miscellaneous revenue.

Recently issued accounting standards: In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures." The ASU enhances the transparency and decision usefulness of income tax disclosures and is effective for annual periods beginning after December 15, 2024 on a prospective basis with the option to apply the standard retrospectively. The Company is currently evaluating the impact of this ASU on its Consolidated Financial Statements and related disclosures.

In November 2024, the FASB issued ASU 2024-03, "Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses." The ASU requires disclosures about specific types of expenses, including purchases of inventory, employee compensation, depreciation and amortization. The amendments in this ASU are effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of this ASU on its Consolidated Financial Statements and related disclosures.

In September 2025, the FASB issued ASU 2025-06, "Intangible - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software." The ASU removes all references to prescriptive and sequential software development stages. The ASU requires entities to begin capitalizing software costs when management authorizes and commits to funding the software project, and it is probable that the project will be completed and the software will be used for its intended purpose. The amendments in this ASU are effective for fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of this ASU on its Consolidated Financial Statements and related disclosures.
v3.25.3
FAIR VALUE MEASUREMENTS
6 Months Ended
Sep. 06, 2025
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS
The accounting guidance for fair value established a framework for measuring fair value and established a three-level valuation hierarchy for disclosure of fair value measurement. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability at the measurement date. The three levels are defined as follows:
Level 1 - Quoted prices in active markets for identical assets or liabilities;
Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and
Level 3 - Unobservable inputs in which little or no market activity exists, requiring an entity to develop its own assumptions that market participants would use to value the asset or liability.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

The following table presents certain assets which were measured at fair value on a recurring basis as of September 6, 2025 (in millions):
Fair Value Measurements
TotalQuoted prices in active markets
 for identical assets
(Level 1)
Significant
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Assets:
Short-term investments (1)$16.2 $7.2 $9.0 $— 
Non-current investments (2)113.7 8.0 105.7 — 
Derivative contracts (3)0.7 — 0.7 — 
Total$130.6 $15.2 $115.4 $— 
Liabilities:
Derivative contracts (3)$0.5 $— $0.5 $— 
Total$0.5 $— $0.5 $— 
(1) Primarily relates to Mutual Funds (Level 1) and Certificates of Deposit (Level 2). Included in Other current assets.
(2) Primarily relates to investments in Exchange-Traded Funds (Level 1) and certain equity investments, U.S. Treasury Notes and Corporate Bonds (Level 2). Included in Other assets.
(3) Primarily relates to energy derivative contracts. Included in Other assets and Other current liabilities.
The following table presents certain assets which were measured at fair value on a recurring basis as of February 22, 2025 (in millions):
 Fair Value Measurements
TotalQuoted prices in active markets
 for identical assets
(Level 1)
Significant
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Assets:
Short-term investments (1)$41.3 $6.8 $34.5 $— 
Non-current investments (2)118.8 7.2 111.6 — 
Derivative contracts (3)0.3 — 0.3 — 
Total$160.4 $14.0 $146.4 $— 
Liabilities:
Derivative contracts (3)$0.6 $— $0.6 $— 
Total$0.6 $— $0.6 $— 
(1) Primarily relates to Mutual Funds (Level 1), and certain equity investments and Certificates of Deposit (Level 2). Included in Other current assets.
(2) Primarily relates to investments in Exchange-Traded Funds (Level 1) and certain equity investments, U.S. Treasury Notes and Corporate Bonds (Level 2). Included in Other assets.
(3) Primarily relates to energy derivative contracts. Included in Other assets or Other current liabilities.

The Company records cash and cash equivalents, restricted cash, accounts receivable and accounts payable at cost. The recorded values of these financial instruments approximate fair value based on their short-term nature.

The estimated fair value of the Company's debt, including current maturities, was based on Level 2 inputs, being market quotes or values for similar instruments, and interest rates currently available to the Company for the issuance of debt with similar terms and remaining maturities as a discount rate for the remaining principal payments. As of September 6, 2025, the fair value of total debt was $7,778.7 million compared to the carrying value of $7,777.1 million, excluding debt discounts and deferred financing costs. As of February 22, 2025, the fair value of total debt was $7,312.1 million compared to the carrying value of $7,452.4 million, excluding debt discounts and deferred financing costs.
Assets Measured at Fair Value on a Non-Recurring Basis

The Company measures certain assets at fair value on a non-recurring basis, including long-lived assets and goodwill, which are evaluated for impairment. Long-lived assets include store-related assets such as property and equipment, operating lease assets and certain intangible assets. The inputs used to determine the fair value of long-lived assets and a reporting unit are considered Level 3 measurements due to their subjective nature.

During the 12 and 28 weeks ended September 6, 2025, the Company recorded retail store impairment losses of $6.2 million and $8.4 million, respectively. During the 12 and 28 weeks ended September 7, 2024, the Company recorded impairment losses of $39.8 million, primarily related to equipment from the closing of our micro-fulfillment centers and $13.5 million of retail store impairment losses. The impairment losses are included as a component of Loss (gain) on property dispositions and impairment losses, net.
v3.25.3
LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS
6 Months Ended
Sep. 06, 2025
Debt Disclosure [Abstract]  
LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS
The Company's long-term debt and finance lease obligations as of September 6, 2025 and February 22, 2025, net of unamortized debt discounts of $26.0 million and $28.6 million, respectively, and deferred financing costs of $30.6 million and $31.6 million, respectively, consisted of the following (in millions):
September 6,
2025
February 22,
2025
Senior Unsecured Notes due 2026 to 2033, interest rate range of 3.25% to 6.50%
$6,517.9 $6,517.0 
New Albertsons L.P. Notes due 2026 to 2031, interest rate range of 6.52% to 8.70%
487.0 484.6 
Safeway Inc. Notes due 2027 to 2031, interest rate range of 7.25% to 7.45%
376.2 375.9 
ABL Facility325.0 — 
Other financing obligations14.4 14.7 
Finance lease obligations 406.0 427.9 
Total debt8,126.5 7,820.1 
Less current maturities(1,186.4)(57.6)
Long-term portion$6,940.1 $7,762.5 

ABL Facility

As of September 6, 2025, there was $325.0 million outstanding under the asset-based loan facility (the "ABL Facility"), and letters of credit ("LOC") issued under the LOC sub-facility were $11.4 million. As of February 22, 2025, there were no amounts outstanding under the ABL Facility and LOC issued under the LOC sub-facility were $27.4 million.

On August 27, 2025, the Company's existing ABL Facility, which provides for a $4,000.0 million senior secured revolving credit facility, was amended and restated to, among other things, extend the maturity date of the facility to August 27, 2030. The new ABL Facility has an interest rate of term SOFR plus a margin ranging from 1.25% to 1.50% and also provides for a LOC sub-facility of $1,500.0 million. As part of the amendment, the Company capitalized $11.9 million of deferred financing costs, recorded within Other assets, and wrote-off $1.4 million of unamortized deferred financing costs to Interest expense, net.

Senior Unsecured Notes

On March 11, 2025, the Company and certain of its subsidiaries (the "Subsidiary Co-Issuers") completed the issuance of $600.0 million in aggregate principal amount of 6.250% senior unsecured notes due March 15, 2033 (the "2033 Notes"). The 2033 Notes are guaranteed on a senior unsecured basis by all of the Company's existing and future direct and indirect domestic subsidiaries (other than the Subsidiary Co-Issuers) that are obligors under the ABL Facility. Interest on the 2033 Notes is payable semi-annually in arrears on March 15 and September 15 of each year, with the first payment commencing on September 15, 2025. On March 17, 2025, proceeds from the 2033 Notes, together with approximately $5.7 million of cash on hand, were used to (i) redeem in full the $600.0 million outstanding of the Company's 7.500% senior unsecured notes due March 15, 2026 (the "Refinancing") and (ii) pay fees and expenses related to the Refinancing and the issuance of the 2033 Notes.
v3.25.3
EMPLOYEE BENEFIT PLANS
6 Months Ended
Sep. 06, 2025
Retirement Benefits [Abstract]  
EMPLOYEE BENEFIT PLANS EMPLOYEE BENEFIT PLANS
Pension and Other Post-Retirement Benefits

The following table provides the components of net pension and post-retirement (income) expense (in millions):
12 weeks ended
PensionOther post-retirement benefits
September 6,
2025
September 7,
2024
September 6,
2025
September 7,
2024
Estimated return on plan assets$(21.2)$(21.1)$— $— 
Service cost3.8 3.9 — — 
Interest cost18.1 19.3 0.2 0.1 
Amortization of prior service cost0.1 0.1 — — 
Amortization of net actuarial gain(0.7)(0.8)(0.2)(0.2)
Settlement (income) loss(26.8)4.7 — — 
(Income) expense, net$(26.7)$6.1 $— $(0.1)
28 weeks ended
PensionOther post-retirement benefits
September 6,
2025
September 7,
2024
September 6,
2025
September 7,
2024
Estimated return on plan assets$(49.5)$(49.2)$— $— 
Service cost8.7 9.0 — — 
Interest cost42.3 45.2 0.3 0.3 
Amortization of prior service cost0.2 0.2 — — 
Amortization of net actuarial gain(1.6)(2.0)(0.4)(0.4)
Settlement (income) loss(26.8)4.7 — — 
(Income) expense, net$(26.7)$7.9 $(0.1)$(0.1)

The Company contributed $3.0 million and $45.9 million to its defined pension plans and post-retirement benefit plans during the 12 and 28 weeks ended September 6, 2025, respectively. For the 12 and 28 weeks ended September 7, 2024, the Company contributed $24.4 million and $37.1 million, respectively. At the Company's discretion, additional funds may be contributed to the defined benefit pension plans that are determined to be beneficial to the Company. The Company currently anticipates contributing an additional $12.2 million to these plans for the remainder of fiscal 2025.

During the 12 and 28 weeks ended September 6, 2025, the Company purchased a group annuity policy and transferred $290.0 million of pension plan assets to an insurance company, thereby reducing the Company's defined benefit pension obligations by $295.0 million. As a result of the annuity purchase, the Company recorded a settlement gain of $26.8 million during the 12 and 28 weeks ended September 6, 2025.
v3.25.3
COMMITMENTS AND CONTINGENCIES AND OFF BALANCE SHEET ARRANGEMENTS
6 Months Ended
Sep. 06, 2025
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES AND OFF BALANCE SHEET ARRANGEMENTS COMMITMENTS AND CONTINGENCIES AND OFF BALANCE SHEET ARRANGEMENTS
Guarantees

Lease Guarantees: The Company may have liability under certain operating leases that were assigned to third parties. If any of these third parties fail to perform their obligations under the leases, the Company could be responsible for the lease obligation. Because of the wide dispersion among third parties and the variety of remedies
available, the Company believes that if an assignee became insolvent, it would not have a material effect on the Company's financial condition, results of operations or cash flows.

The Company also provides guarantees, indemnifications and assurances to others in the ordinary course of its business.

Legal Proceedings

The Company is subject from time to time to various claims and lawsuits, including matters involving trade, business and operational practices, personnel and employment issues, lawsuits alleging violations of state and/or federal wage and hour laws, real estate disputes, personal injury, antitrust claims, packaging or product claims, claims related to the sale of drug or pharmacy products, such as opioids, intellectual property claims and other proceedings arising in or outside of the ordinary course of business. Some of these claims or suits purport or may be determined to be class actions and/or seek substantial damages. It is the opinion of the Company's management that although the amount of liability with respect to certain of the matters described herein cannot be ascertained at this time, any resulting liability of these and other matters, including any punitive damages, will not have a material adverse effect on the Company's business or overall financial condition.

The Company continually evaluates its exposure to loss contingencies arising from pending or threatened litigation and believes it has made provisions where the loss contingency is probable and can be reasonably estimated. Nonetheless, assessing and predicting the outcomes of these matters involves substantial uncertainties. While management currently believes that the aggregate estimated liabilities currently recorded are reasonable, it is reasonably possible that differences in actual outcomes or changes in management's evaluation or predictions could arise that could be material to the Company's results of operations or cash flows.

False Claims Act: Two qui tam actions alleging violations of the False Claims Act ("FCA") have been filed against the Company and its subsidiaries. Violations of the FCA are subject to treble damages and penalties of up to a specified dollar amount per false claim.

In United States ex rel. Proctor v. Safeway, filed in the United States District Court for the Central District of Illinois, the relator alleges that Safeway overcharged federal government healthcare programs by not providing the federal government, as part of its usual and customary prices, the benefit of discounts given to customers in pharmacy membership discount and price-matching programs. The relator filed his complaint under seal on November 11, 2011, and the complaint was unsealed on August 26, 2015. The relator amended the complaint on March 31, 2016. On June 12, 2020, the District Court granted Safeway's motion for summary judgment, holding that the relator could not prove that Safeway acted with the intent required under the FCA, and judgment was issued on June 15, 2020. On July 10, 2020, the relator filed a motion to alter or amend the judgment and to supplement the record, which Safeway opposed. On November 13, 2020, the District Court denied relator's motion, and on December 11, 2020, relator filed a notice of appeal. The Seventh Circuit Court of Appeals affirmed the judgment in the Company's favor on April 5, 2022. On August 3, 2022, relators filed a petition seeking review by the U.S. Supreme Court.

In United States ex rel. Schutte and Yarberry v. SuperValu, New Albertson's, Inc., et al., also filed in the Central District of Illinois, the relators allege that defendants (including various subsidiaries of the Company) overcharged federal government healthcare programs by not providing the federal government, as a part of usual and customary prices, the benefit of discounts given to customers who requested that defendants match competitor prices. The complaint was originally filed under seal and amended on November 30, 2015. On August 5, 2019, the District Court granted relators' motion for partial summary judgment, holding that price-matched prices are the usual and customary prices for those drugs. On July 1, 2020, the District Court granted the defendants' motions for summary judgment and dismissed the case, holding that the relator could not prove that defendants acted with the intent required under the FCA. Judgment was issued on July 2, 2020. On July 9, 2020, the relators filed a notice of appeal.
On August 12, 2021, the Court of Appeals for the Seventh Circuit affirmed the grant of summary judgment in the Company's favor. On September 23, 2021, the relators filed a petition for rehearing en banc with the Seventh Circuit. On December 3, 2021, the Seventh Circuit denied relators' petition. On April 1, 2022, relators filed a petition seeking review by the U.S. Supreme Court.

The U.S. Supreme Court decided to hear the appeals filed by the relators in Proctor and Schutte. The Supreme Court consolidated the two cases for the purpose of hearing the appeal. The Supreme Court heard oral arguments on April 18, 2023. On June 1, 2023, the Supreme Court issued an opinion adverse to the Company, reversing the lower court's rulings. On July 3, 2023, the Supreme Court issued the order remanding both cases back to the Court of Appeals for the Seventh Circuit for further review. On July 27, 2023, the Court of Appeals remanded both cases back to the U.S. District Court for the Central District of Illinois.

On August 22, 2023, the District Court - as to Schutte - set a pretrial conference for March 4, 2024, and a trial date of April 29, 2024. At the same July 27 hearing, the District Court also gave the defendants leave to file motions for summary judgment on a schedule to be agreed upon. On October 11, 2023, the Company and co-defendant filed a motion for summary judgment. On the same day, the relators filed motions for partial summary judgment. On February 16, 2024, the Company and co-defendant filed a motion to reconsider a prior grant of partial summary judgment against the defendants, and also a motion to continue the trial. On February 27, 2024, the District Court granted the motion to continue and vacated the April 29, 2024 trial date. On April 26, 2024, the District Court denied the motion for reconsideration of partial summary judgment. On May 20, 2024, the District Court heard oral argument on the pending motions for summary judgment. On September 30, 2024, the District Court denied both parties' motions for summary judgment on scienter and granted relators' motion for summary judgment on materiality. On November 18, 2024, the District Court denied a motion by the Company to reconsider the materiality ruling or certify that ruling for an interlocutory appeal. The Schutte trial began on February 10, 2025. On March 4, 2025, the Company prevailed at trial and the District Court entered judgment in favor of the Company on March 12, 2025. On April 1, 2025, the relators filed a motion to amend the judgment and grant a new trial on damages. The Court has not ruled on the relators' motion.

Trial in the Proctor case is now scheduled to begin on June 22, 2026.

In both of the above cases, the federal government previously investigated the relators' allegations and declined to intervene. The relators elected to pursue their respective cases on their own and in each case have alleged FCA damages in excess of $100 million before trebling and excluding penalties. The Company is vigorously defending each of these matters. The Company has recorded an estimated liability for these matters.

Pharmacy Benefit Manager (PBM) Litigation: The Company (including its subsidiary, Safeway Inc.) is a defendant in a lawsuit filed on January 21, 2021, in Minnesota state court, captioned Health Care Service Corp. et al. v. Albertsons Companies, LLC, et al. The action challenges certain prescription-drug prices reported by the Company to a pharmacy benefit manager, Prime Therapeutics LLC ("Prime"), which in turn contracted with the health-insurer plaintiffs to adjudicate and process prescription-drug reimbursement claims.

On December 7, 2021, the Company filed a motion to dismiss the complaint. On January 14, 2022, the court denied the Company's motion to dismiss as to all but one count, plaintiffs' claim of negligent misrepresentation. On January 21, 2022, the Company and co-defendant SUPERVALU, Inc. ("SUPERVALU") filed a third-party complaint against Prime, asserting various claims, including: indemnification, fraud and unjust enrichment. On February 17, 2022, the Company filed in the Minnesota Court of Appeals an interlocutory appeal of the denial of their motion to dismiss on personal jurisdiction grounds (the "Jurisdictional Appeal"). On February 24, 2022, the Company and SUPERVALU filed in the trial court an unopposed motion to stay proceedings, pending the resolution of the Jurisdictional Appeal. The parties agreed on March 6, 2022, to an interim stay in the trial court pending a ruling on the unopposed motion to stay proceedings. On September 6, 2022, the Minnesota Court of Appeals denied the Jurisdictional Appeal and affirmed the trial court’s denial of the Company’s motion to dismiss. On October 6, 2022,
the Company and SUPERVALU filed a petition seeking review by the Minnesota Supreme Court. On November 23, 2022, the Minnesota Supreme Court denied that petition. The Company and co-defendant SUPERVALU filed an answer to the complaint on January 23, 2023. On March 9, 2023, Prime moved to dismiss the third-party complaint filed by the Company and SUPERVALU. The court heard oral arguments on the motion on May 11, 2023. On August 9, 2023, the court denied Prime's motion as to 16 of the 17 counts in the third-party complaint, and dismissed one count without prejudice. On September 18, 2023, the Company and SUPERVALU filed an amended third-party complaint, which repleaded the one count that had been dismissed (in addition to the other claims asserted in the initial third-party complaint). On October 2, 2023, Prime filed an answer to the amended third-party complaint. The proceedings were stayed through September 29, 2025 to facilitate settlement discussions. The case is currently scheduled to be ready for trial on or after February 18, 2027. On October 9, 2025, the Company, SUPERVALU, and Prime filed a stipulated motion requesting the dismissal of Prime from the litigation, which was approved by the Court on October 10, 2025, thus dismissing Prime.

The Company is vigorously defending the claims filed against it. The Company has recorded an estimated liability for this matter.

Opioid Litigation: The Company is one of dozens of companies that have been named as defendants in lawsuits filed by various plaintiffs, including states, counties, cities, Native American tribes, and hospitals, alleging that defendants contributed to the national opioid epidemic. At present, the Company is a named defendant in approximately 81 suits pending in various state and federal courts including the United States District Court for the Northern District of Ohio, where over 2,000 cases against various defendants have been consolidated as Multi-District Litigation ("MDL") pursuant to 28 U.S.C. §1407. All of the MDL cases naming the Company have been stayed except for two so called "bellwether" actions in Tarrant County (Texas) and Monterey County (California). Discovery has been completed on Tarrant County's liability claim and the matter has been remanded to the Northern District of Texas for trial. On July 25, 2025, the Company filed a motion with the Court seeking to certify the Motion for Summary Judgment Order for introductory appeal before the Fifth Circuit, which is fully briefed and pending before the Court. Discovery in Monterey County (California) is ongoing. The relief sought by the various plaintiffs in these matters includes compensatory damages, abatement and punitive damages as well as injunctive relief. On July 30, 2024, multiple plaintiffs filed an Omnibus Motion for Leave to Amend complaints, seeking leave from the MDL court to add the Company to over 150 of additional lawsuits. The Company filed its response to the Omnibus Motion on January 16, 2025. In the reply filed by the plaintiffs on July 2, 2025, the number of additional lawsuits was reduced to approximately 108 suits. The Motion remains pending before the Court.

Prior to the start of a state-court trial that was scheduled for September 6, 2022, the Company reached an agreement to settle with the State of New Mexico. The New Mexico counties and municipal entities that filed 14 additional lawsuits, including Santa Fe County, agreed to the terms of the settlement. Thus, all 15 cases filed by New Mexico entities have been dismissed as a result of the settlement. The Company executed an agreement to settle three matters that were filed in Nevada. The Company recorded a liability of $21.5 million for the settlements of the cases in New Mexico and Nevada which was paid by its insurers in the fourth quarter of fiscal 2022. With respect to the three active state court claims, those matters are in Dallas County (Texas), the State of Washington and the City of Philadelphia (Pennsylvania). The State of Washington matter is scheduled for trial on May 4, 2026. The Company requested an interlocutory appeal with the City of Philadelphia matter, which was granted on November 26, 2024. The City of Philadelphia appeal was heard on July 15, 2025, and the Company awaits the Court's ruling. The Company also requested an interlocutory appeal with the Dallas County matter, which was granted on March 7, 2025. On September 5, 2025, the Texas Supreme Court denied the Company's appeal. On September 22, 2025, the Company filed a motion seeking a rehearing of the denial. The Company believes that it has substantial factual and legal defenses to these claims, and is vigorously defending these matters. At this stage in the proceedings, the Company is unable to determine the probability of the outcome of these remaining matters or the range of reasonably possible loss.
The Company has also received subpoenas, Civil Investigative Demands and other requests for documents and information from the U.S. Department of Justice ("DOJ") and certain state Attorneys General, and has had preliminary discussions with the DOJ with respect to purported violations of the federal Controlled Substances Act and the FCA in dispensing prescriptions. The Company has been cooperating with the government with respect to these requests for information.

Termination of the Merger Agreement: As previously disclosed, on October 13, 2022, the Company, The Kroger Co. ("Kroger") and Kettle Merger Sub, Inc., a wholly owned subsidiary of Kroger ("Merger Sub"), entered into an Agreement and Plan of Merger (the "Merger Agreement"), pursuant to which Merger Sub would have been merged with and into the Company (the "Merger"), with the Company surviving the Merger as the surviving corporation and a direct, wholly owned subsidiary of Kroger.

As previously disclosed, On December 10, 2024, the United States District Court for the District of Oregon issued a preliminary injunction in the case Federal Trade Commission et al. v. The Kroger Company and Albertsons Companies, Inc. (Case No.: 3:24-cv-00347-AN), whereby the court enjoined the consummation of the Merger. A permanent injunction was issued, also on December 10, 2024, by a state court judge in a lawsuit brought against Kroger and the Company by the State of Washington, in the case State of Washington v. The Kroger Company and Albertsons Companies, Inc., King County Superior Court, Washington (Case No. 24-2-00977-9 SEA). In light of the injunctions, and in accordance with Section 8.1(e) of the Merger Agreement, the Company exercised its right to terminate the Merger Agreement and sent a notice to Kroger on December 10, 2024 terminating the Merger Agreement.

Following the Company's termination of the Merger Agreement, on December 10, 2024, the Company filed a lawsuit against Kroger in the Court of Chancery in the State of Delaware, bringing claims for willful breach of the Merger Agreement and breach of the covenant of good faith and fair dealing arising from Kroger's failure to exercise "best efforts" and to take "any and all actions" to secure regulatory approval, as was required of Kroger under the terms of the Merger Agreement. The Company is seeking damages in an amount to be determined at trial, in addition to the $600 million termination fee which Kroger is already obligated to pay to the Company under the Merger Agreement.

On December 11, 2024, Kroger delivered a termination notice to the Company, alleging that the Company's December 10, 2024 termination notice was not effective and that Kroger had no obligation to pay the $600 million termination fee because the Company allegedly failed to perform and comply in all material respects with its covenants under the Merger Agreement. On March 25, 2025, Kroger answered the Company's lawsuit and brought counterclaims against the Company in connection with the Company's alleged failure to perform under the Merger Agreement. The Company filed its answers to Kroger's counterclaims on May 17, 2025 and the parties are presently engaged in discovery. Trial is scheduled to begin on October 19, 2026.

On August 19, 2025, the Court in the State of Washington's case against Kroger and the Company awarded the State $28.4 million in attorneys' fees and costs as the prevailing party, with post-judgment interest accruing at 12%. The judgment was entered jointly and severally against Kroger and the Company. Kroger and the Company disagree with the Court's decision in awarding the State of Washington its attorneys' fees and costs, and the decision is being appealed. Kroger has filed a supersedeas bond with respect to the judgment for purposes of the appeal. The Company believes, based on the terms of the Merger Agreement, that Kroger is solely responsible for the full payment of the judgment and, accordingly, the Company has not recorded a liability.
Other Commitments
In the ordinary course of business, the Company enters into various supply contracts for goods and contracts for fixed assets and information technology. These contracts typically include volume commitments or fixed expiration dates, termination provisions and other standard contractual considerations.
v3.25.3
OTHER COMPREHENSIVE INCOME OR LOSS
6 Months Ended
Sep. 06, 2025
Equity [Abstract]  
OTHER COMPREHENSIVE INCOME OR LOSS OTHER COMPREHENSIVE INCOME OR LOSS
Total comprehensive earnings are defined as all changes in stockholders' equity during a period, other than those from investments by or distributions to the stockholders. Generally, for the Company, total comprehensive income equals net income plus or minus adjustments for pension and other post-retirement liabilities. Total comprehensive earnings represent the activity for a period, net of tax.

While total comprehensive earnings are the activity in a period and are largely driven by net earnings in that period, accumulated other comprehensive income or loss ("AOCI") represents the cumulative balance of other comprehensive income, net of tax, as of the balance sheet date. Changes in the AOCI balance by component are shown below (in millions):
28 weeks ended September 6, 2025
TotalPension and Post-retirement benefit plansOther
Beginning AOCI balance$94.7 $92.4 $2.3 
Other comprehensive income before reclassifications11.7 9.6 2.1 
Amounts reclassified from accumulated other comprehensive income (1)(28.6)(28.6)— 
Tax benefit (expense)4.4 4.9 (0.5)
Current-period other comprehensive (loss) income, net of tax(12.5)(14.1)1.6 
Ending AOCI balance$82.2 $78.3 $3.9 

28 weeks ended September 7, 2024
TotalPension and Post-retirement benefit plansOther
Beginning AOCI balance$88.0 $87.5 $0.5 
Other comprehensive income before reclassifications3.7 — 3.7 
Amounts reclassified from accumulated other comprehensive income (1)2.5 2.5 — 
Tax expense (1.6)(0.6)(1.0)
Current-period other comprehensive income, net of tax4.6 1.9 2.7 
Ending AOCI balance$92.6 $89.4 $3.2 
(1) These amounts are included in the computation of net pension and post-retirement expense (income). For additional information, see Note 4 - Employee Benefit Plans.
v3.25.3
SEGMENT INFORMATION
6 Months Ended
Sep. 06, 2025
Segment Reporting [Abstract]  
SEGMENT INFORMATION SEGMENT INFORMATION
The Company and its subsidiaries offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel and other items and services in its stores or through digital channels. The Company's retail operating divisions are geographically based, have similar economic characteristics and similar expected long-term financial
performance. The Company's operating segments and reporting units are its operating divisions, which are reported in one reportable segment. Each reporting unit constitutes a business for which discrete financial information is available and for which the Chief Operating Decision Maker ("CODM"), the Company's Chief Executive Officer, regularly reviews the operating results and makes key operating decisions on how to allocate resources. Across all operating segments, the Company operates primarily one store format. Each division offers, through its stores and digital channels, the same general mix of products with similar pricing to similar categories of customers, has similar distribution methods, operates in similar regulatory environments and purchases merchandise from similar or the same vendors.

The CODM evaluates performance and allocates resources using Retail segment EBITDA, defined as earnings (net loss) before interest, income taxes, depreciation and amortization, adjusted to eliminate the effects of items management does not consider in assessing segment performance. The CODM uses Retail segment EBITDA as its principal measure of segment performance to evaluate the Company's operating results and effectiveness of its strategies and to monitor budget versus actual results.

The CODM is not provided asset information by operating segment as asset information is provided to the CODM on a consolidated basis. No customer accounts for 10% or more of the Company's revenues. Substantially all of the Company's revenues are generated in the U.S. and its long-lived assets are predominantly located within the U.S. The accounting policies of the reportable segment generally align with those described in the Company’s summary of significant accounting policies contained in Note 1, except certain classification differences that are not material for all periods presented.
The following table presents segment information for Net sales and other revenue, significant segment expenses and Retail segment EBITDA (in millions):
12 weeks ended28 weeks ended
September 6,
2025
September 7,
2024
September 6,
2025
September 7,
2024
Retail segment sales$18,728.9 $18,365.4 $43,373.3 $42,407.0 
Other revenue (1)186.9 186.1 423.3 409.9 
Net sales and other revenue$18,915.8 $18,551.5 $43,796.6 $42,816.9 
Retail segment expenses:
Merchandise costs, including advertising, distribution and freight13,395.0 13,077.5 31,015.9 30,164.0 
Employee costs (2)2,746.7 2,715.5 6,406.9 6,265.6 
Other segment expenses (3)1,595.8 1,546.5 3,676.4 3,581.7 
Retail segment EBITDA$991.4 $1,025.9 $2,274.1 $2,395.7 
Reconciliation to Income before income taxes:
Corporate adjustments (4)(143.0)(125.3)(314.7)(311.2)
Depreciation and amortization(434.7)(421.9)(1,007.4)(973.9)
Interest expense, net(105.3)(103.6)(247.1)(249.3)
Business transformation (5)(35.3)(20.5)(73.6)(37.8)
Equity-based compensation expense(18.7)(29.5)(52.4)(66.2)
(Loss) gain on property dispositions and impairment losses, net(4.4)(43.9)27.5 (49.2)
LIFO expense(11.0)(4.8)(28.3)(19.4)
Merger-related costs (6)(19.0)(67.4)(38.0)(159.7)
Certain legal and regulatory accruals and settlements, net(8.4)(8.7)(11.0)0.2 
Miscellaneous adjustments (7)8.1 (13.8)2.0 (32.8)
Income before income taxes$219.7 $186.5 $531.1 $496.4 
(1) Primarily includes wholesale sales to third parties and other miscellaneous revenue not included in Retail segment sales.
(2) Includes wages, salaries, benefits, insurance and other employee-related costs.
(3) Primarily includes rent and occupancy costs, debit and credit card fees, supplies, divisional support costs and allocated corporate costs.
(4) Primarily includes bonus compensation, unallocated corporate costs and contribution from the Company's wholesale and other sales.
(5) Primarily includes costs associated with third-party consulting fees related to the Company's Customers for Life strategy and costs related to employee terminations.
(6) The 12 and 28 weeks ended September 6, 2025 primarily relates to litigation costs and retention program expense related to the terminated merger. The 12 and 28 weeks ended September 7, 2024 primarily includes third-party legal and advisor fees and retention program expense related to the Merger.
(7) Primarily includes pension settlement gains and losses, net realized and unrealized gains and losses related to non-operating investments, adjustments for closed stores and surplus properties, non-cash rent expense, gains and losses on energy hedges and other items not allocated to the segment.
v3.25.3
NET INCOME PER CLASS A COMMON SHARE
6 Months Ended
Sep. 06, 2025
Earnings Per Share [Abstract]  
NET INCOME PER CLASS A COMMON SHARE NET INCOME PER CLASS A COMMON SHARE
Basic net income per Class A common share is computed by dividing net income by the weighted average number of Class A common shares outstanding for the period, including Class A common shares to be issued with no remaining contingencies prior to issuance. Diluted net income per Class A common share is computed based on the weighted average number of shares of Class A common stock outstanding during the period, adjusted for the
potentially dilutive effect of unvested restricted stock units ("RSUs") and restricted common stock ("RSAs") calculated under the treasury stock method. Performance-based RSUs and RSAs are considered dilutive when the related performance criterion has been met.

The components of basic and diluted net income per Class A common share were as follows (in millions, except per share data):
12 weeks ended28 weeks ended
September 6,
2025
September 7,
2024
September 6,
2025
September 7,
2024
Net income$168.5 $145.5 $404.9 $386.2 
Weighted average Class A common shares outstanding - Basic (1)559.7 580.1 567.3 579.5 
Dilutive effect of restricted stock units and awards2.8 3.1 2.6 2.9 
Weighted average Class A common shares outstanding - Diluted (2)562.5 583.2 569.9 582.4 
Basic net income per Class A common share$0.30 $0.25 $0.71 $0.67 
Diluted net income per Class A common share$0.30 $0.25 $0.71 $0.66 
(1) The number of Class A common shares remaining to be issued for the 12 and 28 weeks ended September 6, 2025 and September 7, 2024 were not material.
(2) The number of potential Class A common shares outstanding related to RSUs and RSAs that were antidilutive for the 12 and 28 weeks ended September 6, 2025 and September 7, 2024 were not material.
v3.25.3
Insider Trading Arrangements
3 Months Ended
Sep. 06, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.3
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended
Sep. 06, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying interim Condensed Consolidated Financial Statements include the accounts of Albertsons Companies, Inc. and its subsidiaries (the "Company"). All significant intercompany balances and transactions were eliminated. The Condensed Consolidated Balance Sheet as of February 22, 2025 is derived from the Company's annual audited Consolidated Financial Statements, which should be read in conjunction with these Condensed Consolidated Financial Statements and which are included in the Company's Annual Report on Form 10-K for the fiscal year ended February 22, 2025, filed with the Securities and Exchange Commission (the "SEC") on April 21, 2025. Certain information in footnote disclosures normally included in annual financial statements was condensed or omitted for the interim periods presented in accordance with accounting principles generally accepted in the United States of America ("GAAP"). In the opinion of management, the interim data includes all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. The interim results of operations and cash flows are not necessarily indicative of those results and cash flows expected for the year. The Company's results of operations are for the 12 and 28 weeks ended September 6, 2025 and September 7, 2024.
Restricted cash Restricted cash: Restricted cash is included in Other current assets or Other assets depending on the remaining term of the restriction and primarily relates to surety bonds.
Inventories, net
Inventories, net: Substantially all of the Company's inventories consist of finished goods valued at the lower of cost or market and net of vendor allowances. The Company primarily uses the retail inventory or cost method to determine inventory cost before application of any last-in, first-out ("LIFO") adjustment. Interim LIFO inventory costs are based on management's estimates of expected year-end inventory levels and inflation rates. The Company recorded LIFO expense of $11.0 million and $4.8 million for the 12 weeks ended September 6, 2025 and September 7, 2024, respectively, and $28.3 million and $19.4 million for the 28 weeks ended September 6, 2025 and September 7, 2024, respectively.
Revenue recognition Revenue recognition: Revenues from the retail sale of products are recognized at the point of sale or delivery to the customer, net of returns and sales tax. Pharmacy sales are recorded upon the customer receiving the prescription.For digital related sales, which primarily include home delivery and Drive Up & Go curbside pickup, revenues are recognized upon either pickup in store or delivery to the customer and may include revenue for separately charged delivery services. The Company records a contract liability when rewards are earned by customers in connection with the Company's loyalty programs. As rewards are redeemed or expire, the Company reduces the contract liability and recognizes revenue. The contract liability balance was immaterial as of September 6, 2025 and February 22, 2025. Media advertising services are classified as either Net sales and other revenue or a reduction in Cost of sales depending on the nature of the media advertising arrangement.The Company records a contract liability when it sells its own proprietary gift cards. The Company records a sale when the customer redeems the gift card. The Company's gift cards do not expire. The Company reduces the contract liability and records revenue for the unused portion of gift cards in proportion to its customers' pattern of redemption, which the Company determined to be the historical redemption rate.
Recently issued accounting standards
Recently issued accounting standards: In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures." The ASU enhances the transparency and decision usefulness of income tax disclosures and is effective for annual periods beginning after December 15, 2024 on a prospective basis with the option to apply the standard retrospectively. The Company is currently evaluating the impact of this ASU on its Consolidated Financial Statements and related disclosures.

In November 2024, the FASB issued ASU 2024-03, "Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses." The ASU requires disclosures about specific types of expenses, including purchases of inventory, employee compensation, depreciation and amortization. The amendments in this ASU are effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of this ASU on its Consolidated Financial Statements and related disclosures.

In September 2025, the FASB issued ASU 2025-06, "Intangible - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software." The ASU removes all references to prescriptive and sequential software development stages. The ASU requires entities to begin capitalizing software costs when management authorizes and commits to funding the software project, and it is probable that the project will be completed and the software will be used for its intended purpose. The amendments in this ASU are effective for fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of this ASU on its Consolidated Financial Statements and related disclosures.
Fair Value Measurements FAIR VALUE MEASUREMENTS
The accounting guidance for fair value established a framework for measuring fair value and established a three-level valuation hierarchy for disclosure of fair value measurement. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability at the measurement date. The three levels are defined as follows:
Level 1 - Quoted prices in active markets for identical assets or liabilities;
Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and
Level 3 - Unobservable inputs in which little or no market activity exists, requiring an entity to develop its own assumptions that market participants would use to value the asset or liability.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.
v3.25.3
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Sep. 06, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Sales Revenue by Type of Similar Products
The following table represents Net sales and other revenue by product type (dollars in millions):
12 weeks ended28 weeks ended
September 6,
2025
September 7,
2024
September 6,
2025
September 7,
2024
Amount (1)% of TotalAmount (1)% of TotalAmount (1)% of TotalAmount (1)% of Total
Non-perishables (2)$9,220.5 48.8 %$9,265.0 49.9 %$21,362.2 48.8 %$21,319.0 49.8 %
Fresh (3)5,946.6 31.4 5,917.4 31.9 13,933.4 31.8 13,822.3 32.3 
Pharmacy2,536.8 13.4 2,132.0 11.5 5,691.8 13.0 4,754.8 11.1 
Fuel911.3 4.8 951.3 5.2 2,141.2 4.9 2,272.2 5.3 
Other (4)300.6 1.6 285.8 1.5 668.0 1.5 648.6 1.5 
Net sales and other revenue$18,915.8 100.0 %$18,551.5 100.0 %$43,796.6 100.0 %$42,816.9 100.0 %
(1) Digital related sales are included in the categories to which the revenue pertains.
(2) Consists primarily of general merchandise, grocery, dairy and frozen foods.
(3) Consists primarily of produce, meat, deli and prepared foods, bakery, floral and seafood.
(4) Consists primarily of wholesale revenue to third parties, commissions, rental income, media advertising revenue and other miscellaneous revenue.
v3.25.3
FAIR VALUE MEASUREMENTS (Tables)
6 Months Ended
Sep. 06, 2025
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table presents certain assets which were measured at fair value on a recurring basis as of September 6, 2025 (in millions):
Fair Value Measurements
TotalQuoted prices in active markets
 for identical assets
(Level 1)
Significant
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Assets:
Short-term investments (1)$16.2 $7.2 $9.0 $— 
Non-current investments (2)113.7 8.0 105.7 — 
Derivative contracts (3)0.7 — 0.7 — 
Total$130.6 $15.2 $115.4 $— 
Liabilities:
Derivative contracts (3)$0.5 $— $0.5 $— 
Total$0.5 $— $0.5 $— 
(1) Primarily relates to Mutual Funds (Level 1) and Certificates of Deposit (Level 2). Included in Other current assets.
(2) Primarily relates to investments in Exchange-Traded Funds (Level 1) and certain equity investments, U.S. Treasury Notes and Corporate Bonds (Level 2). Included in Other assets.
(3) Primarily relates to energy derivative contracts. Included in Other assets and Other current liabilities.
The following table presents certain assets which were measured at fair value on a recurring basis as of February 22, 2025 (in millions):
 Fair Value Measurements
TotalQuoted prices in active markets
 for identical assets
(Level 1)
Significant
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Assets:
Short-term investments (1)$41.3 $6.8 $34.5 $— 
Non-current investments (2)118.8 7.2 111.6 — 
Derivative contracts (3)0.3 — 0.3 — 
Total$160.4 $14.0 $146.4 $— 
Liabilities:
Derivative contracts (3)$0.6 $— $0.6 $— 
Total$0.6 $— $0.6 $— 
(1) Primarily relates to Mutual Funds (Level 1), and certain equity investments and Certificates of Deposit (Level 2). Included in Other current assets.
(2) Primarily relates to investments in Exchange-Traded Funds (Level 1) and certain equity investments, U.S. Treasury Notes and Corporate Bonds (Level 2). Included in Other assets.
(3) Primarily relates to energy derivative contracts. Included in Other assets or Other current liabilities.
v3.25.3
LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS (Tables)
6 Months Ended
Sep. 06, 2025
Debt Disclosure [Abstract]  
Schedule of Long-term Debt
The Company's long-term debt and finance lease obligations as of September 6, 2025 and February 22, 2025, net of unamortized debt discounts of $26.0 million and $28.6 million, respectively, and deferred financing costs of $30.6 million and $31.6 million, respectively, consisted of the following (in millions):
September 6,
2025
February 22,
2025
Senior Unsecured Notes due 2026 to 2033, interest rate range of 3.25% to 6.50%
$6,517.9 $6,517.0 
New Albertsons L.P. Notes due 2026 to 2031, interest rate range of 6.52% to 8.70%
487.0 484.6 
Safeway Inc. Notes due 2027 to 2031, interest rate range of 7.25% to 7.45%
376.2 375.9 
ABL Facility325.0 — 
Other financing obligations14.4 14.7 
Finance lease obligations 406.0 427.9 
Total debt8,126.5 7,820.1 
Less current maturities(1,186.4)(57.6)
Long-term portion$6,940.1 $7,762.5 
v3.25.3
EMPLOYEE BENEFIT PLANS (Tables)
6 Months Ended
Sep. 06, 2025
Retirement Benefits [Abstract]  
Schedule of Components of Net Pension and Post-retirement Expense
The following table provides the components of net pension and post-retirement (income) expense (in millions):
12 weeks ended
PensionOther post-retirement benefits
September 6,
2025
September 7,
2024
September 6,
2025
September 7,
2024
Estimated return on plan assets$(21.2)$(21.1)$— $— 
Service cost3.8 3.9 — — 
Interest cost18.1 19.3 0.2 0.1 
Amortization of prior service cost0.1 0.1 — — 
Amortization of net actuarial gain(0.7)(0.8)(0.2)(0.2)
Settlement (income) loss(26.8)4.7 — — 
(Income) expense, net$(26.7)$6.1 $— $(0.1)
28 weeks ended
PensionOther post-retirement benefits
September 6,
2025
September 7,
2024
September 6,
2025
September 7,
2024
Estimated return on plan assets$(49.5)$(49.2)$— $— 
Service cost8.7 9.0 — — 
Interest cost42.3 45.2 0.3 0.3 
Amortization of prior service cost0.2 0.2 — — 
Amortization of net actuarial gain(1.6)(2.0)(0.4)(0.4)
Settlement (income) loss(26.8)4.7 — — 
(Income) expense, net$(26.7)$7.9 $(0.1)$(0.1)
v3.25.3
OTHER COMPREHENSIVE INCOME OR LOSS (Tables)
6 Months Ended
Sep. 06, 2025
Equity [Abstract]  
Schedule of Changes In the Accumulated Other Comprehensive Income or Loss Changes in the AOCI balance by component are shown below (in millions):
28 weeks ended September 6, 2025
TotalPension and Post-retirement benefit plansOther
Beginning AOCI balance$94.7 $92.4 $2.3 
Other comprehensive income before reclassifications11.7 9.6 2.1 
Amounts reclassified from accumulated other comprehensive income (1)(28.6)(28.6)— 
Tax benefit (expense)4.4 4.9 (0.5)
Current-period other comprehensive (loss) income, net of tax(12.5)(14.1)1.6 
Ending AOCI balance$82.2 $78.3 $3.9 

28 weeks ended September 7, 2024
TotalPension and Post-retirement benefit plansOther
Beginning AOCI balance$88.0 $87.5 $0.5 
Other comprehensive income before reclassifications3.7 — 3.7 
Amounts reclassified from accumulated other comprehensive income (1)2.5 2.5 — 
Tax expense (1.6)(0.6)(1.0)
Current-period other comprehensive income, net of tax4.6 1.9 2.7 
Ending AOCI balance$92.6 $89.4 $3.2 
(1) These amounts are included in the computation of net pension and post-retirement expense (income). For additional information, see Note 4 - Employee Benefit Plans.
v3.25.3
SEGMENT INFORMATION (Tables)
6 Months Ended
Sep. 06, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table presents segment information for Net sales and other revenue, significant segment expenses and Retail segment EBITDA (in millions):
12 weeks ended28 weeks ended
September 6,
2025
September 7,
2024
September 6,
2025
September 7,
2024
Retail segment sales$18,728.9 $18,365.4 $43,373.3 $42,407.0 
Other revenue (1)186.9 186.1 423.3 409.9 
Net sales and other revenue$18,915.8 $18,551.5 $43,796.6 $42,816.9 
Retail segment expenses:
Merchandise costs, including advertising, distribution and freight13,395.0 13,077.5 31,015.9 30,164.0 
Employee costs (2)2,746.7 2,715.5 6,406.9 6,265.6 
Other segment expenses (3)1,595.8 1,546.5 3,676.4 3,581.7 
Retail segment EBITDA$991.4 $1,025.9 $2,274.1 $2,395.7 
Reconciliation to Income before income taxes:
Corporate adjustments (4)(143.0)(125.3)(314.7)(311.2)
Depreciation and amortization(434.7)(421.9)(1,007.4)(973.9)
Interest expense, net(105.3)(103.6)(247.1)(249.3)
Business transformation (5)(35.3)(20.5)(73.6)(37.8)
Equity-based compensation expense(18.7)(29.5)(52.4)(66.2)
(Loss) gain on property dispositions and impairment losses, net(4.4)(43.9)27.5 (49.2)
LIFO expense(11.0)(4.8)(28.3)(19.4)
Merger-related costs (6)(19.0)(67.4)(38.0)(159.7)
Certain legal and regulatory accruals and settlements, net(8.4)(8.7)(11.0)0.2 
Miscellaneous adjustments (7)8.1 (13.8)2.0 (32.8)
Income before income taxes$219.7 $186.5 $531.1 $496.4 
(1) Primarily includes wholesale sales to third parties and other miscellaneous revenue not included in Retail segment sales.
(2) Includes wages, salaries, benefits, insurance and other employee-related costs.
(3) Primarily includes rent and occupancy costs, debit and credit card fees, supplies, divisional support costs and allocated corporate costs.
(4) Primarily includes bonus compensation, unallocated corporate costs and contribution from the Company's wholesale and other sales.
(5) Primarily includes costs associated with third-party consulting fees related to the Company's Customers for Life strategy and costs related to employee terminations.
(6) The 12 and 28 weeks ended September 6, 2025 primarily relates to litigation costs and retention program expense related to the terminated merger. The 12 and 28 weeks ended September 7, 2024 primarily includes third-party legal and advisor fees and retention program expense related to the Merger.
(7) Primarily includes pension settlement gains and losses, net realized and unrealized gains and losses related to non-operating investments, adjustments for closed stores and surplus properties, non-cash rent expense, gains and losses on energy hedges and other items not allocated to the segment.
v3.25.3
NET INCOME PER CLASS A COMMON SHARE (Tables)
6 Months Ended
Sep. 06, 2025
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Net Loss Per Share
The components of basic and diluted net income per Class A common share were as follows (in millions, except per share data):
12 weeks ended28 weeks ended
September 6,
2025
September 7,
2024
September 6,
2025
September 7,
2024
Net income$168.5 $145.5 $404.9 $386.2 
Weighted average Class A common shares outstanding - Basic (1)559.7 580.1 567.3 579.5 
Dilutive effect of restricted stock units and awards2.8 3.1 2.6 2.9 
Weighted average Class A common shares outstanding - Diluted (2)562.5 583.2 569.9 582.4 
Basic net income per Class A common share$0.30 $0.25 $0.71 $0.67 
Diluted net income per Class A common share$0.30 $0.25 $0.71 $0.66 
(1) The number of Class A common shares remaining to be issued for the 12 and 28 weeks ended September 6, 2025 and September 7, 2024 were not material.
(2) The number of potential Class A common shares outstanding related to RSUs and RSAs that were antidilutive for the 12 and 28 weeks ended September 6, 2025 and September 7, 2024 were not material.
v3.25.3
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended
Sep. 06, 2025
Sep. 07, 2024
Sep. 06, 2025
Sep. 07, 2024
Oct. 14, 2025
Oct. 13, 2025
Feb. 22, 2025
New Accounting Pronouncements or Change in Accounting Principle [Line Items]              
Restricted cash $ 4.4   $ 4.4       $ 4.3
LIFO expense 11.0 $ 4.8 28.3 $ 19.4      
Income tax expense $ 51.2 $ 41.0 $ 126.2 $ 110.2      
Effective tax rate 23.30% 22.00% 23.80% 22.20%      
Receivables, net $ 968.8   $ 968.8       834.8
Contract liability related to gift cards 105.2   105.2       119.9
Subsequent Event              
New Accounting Pronouncements or Change in Accounting Principle [Line Items]              
Accelerated share repurchase agreement amount         $ 750.0    
Share repurchase program amount         $ 2,750.0 $ 2,000.0  
Pharmacy              
New Accounting Pronouncements or Change in Accounting Principle [Line Items]              
Receivables, net $ 542.2   $ 542.2       $ 464.1
Class A-1 convertible common stock              
New Accounting Pronouncements or Change in Accounting Principle [Line Items]              
Common stock, shares authorized (in shares) 150,000,000   150,000,000       150,000,000
Common stock, par value (in dollars per share) $ 0.01   $ 0.01       $ 0.01
Common stock shares issued (in shares) 0   0       0
Convertible Preferred Stock              
New Accounting Pronouncements or Change in Accounting Principle [Line Items]              
Preferred stock, shares authorized (in shares) 100,000,000   100,000,000       100,000,000
Preferred stock, par value (in dollars per share) $ 0.01   $ 0.01       $ 0.01
Series A Convertible Preferred Stock              
New Accounting Pronouncements or Change in Accounting Principle [Line Items]              
Preferred stock, shares authorized (in shares) 1,750,000   1,750,000       1,750,000
Series A-1 Convertible Preferred Stock              
New Accounting Pronouncements or Change in Accounting Principle [Line Items]              
Preferred stock, shares authorized (in shares) 1,410,000   1,410,000       1,410,000
Undesignated preferred stock              
New Accounting Pronouncements or Change in Accounting Principle [Line Items]              
Preferred stock, shares issued (in shares) 0   0       0
v3.25.3
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Sales Revenue by Similar Products (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Sep. 06, 2025
Sep. 07, 2024
Sep. 06, 2025
Sep. 07, 2024
Concentration Risk [Line Items]        
Net sales and other revenue $ 18,915.8 $ 18,551.5 $ 43,796.6 $ 42,816.9
Product Line | Product Concentration Risk        
Concentration Risk [Line Items]        
Net sales and other revenue $ 18,915.8 $ 18,551.5 $ 43,796.6 $ 42,816.9
Percentage of total net sales and other revenue 100.00% 100.00% 100.00% 100.00%
Non-perishables | Product Line | Product Concentration Risk        
Concentration Risk [Line Items]        
Net sales and other revenue $ 9,220.5 $ 9,265.0 $ 21,362.2 $ 21,319.0
Percentage of total net sales and other revenue 48.80% 49.90% 48.80% 49.80%
Fresh | Product Line | Product Concentration Risk        
Concentration Risk [Line Items]        
Net sales and other revenue $ 5,946.6 $ 5,917.4 $ 13,933.4 $ 13,822.3
Percentage of total net sales and other revenue 31.40% 31.90% 31.80% 32.30%
Pharmacy | Product Line | Product Concentration Risk        
Concentration Risk [Line Items]        
Net sales and other revenue $ 2,536.8 $ 2,132.0 $ 5,691.8 $ 4,754.8
Percentage of total net sales and other revenue 13.40% 11.50% 13.00% 11.10%
Fuel | Product Line | Product Concentration Risk        
Concentration Risk [Line Items]        
Net sales and other revenue $ 911.3 $ 951.3 $ 2,141.2 $ 2,272.2
Percentage of total net sales and other revenue 4.80% 5.20% 4.90% 5.30%
Other | Product Line | Product Concentration Risk        
Concentration Risk [Line Items]        
Net sales and other revenue $ 300.6 $ 285.8 $ 668.0 $ 648.6
Percentage of total net sales and other revenue 1.60% 1.50% 1.50% 1.50%
v3.25.3
FAIR VALUE MEASUREMENTS - Schedule of Assets and Liabilities Measured at Fair Value (Details) - Recurring - USD ($)
$ in Millions
Sep. 06, 2025
Feb. 22, 2025
Assets:    
Short-term investments $ 16.2 $ 41.3
Non-current investments 113.7 118.8
Derivative contracts 0.7 0.3
Total 130.6 160.4
Liabilities:    
Derivative contracts 0.5 0.6
Total 0.5 0.6
Quoted prices in active markets for identical assets (Level 1)    
Assets:    
Short-term investments 7.2 6.8
Non-current investments 8.0 7.2
Derivative contracts 0.0 0.0
Total 15.2 14.0
Liabilities:    
Derivative contracts 0.0 0.0
Total 0.0 0.0
Significant observable inputs (Level 2)    
Assets:    
Short-term investments 9.0 34.5
Non-current investments 105.7 111.6
Derivative contracts 0.7 0.3
Total 115.4 146.4
Liabilities:    
Derivative contracts 0.5 0.6
Total 0.5 0.6
Significant unobservable inputs (Level 3)    
Assets:    
Short-term investments 0.0 0.0
Non-current investments 0.0 0.0
Derivative contracts 0.0 0.0
Total 0.0 0.0
Liabilities:    
Derivative contracts 0.0 0.0
Total $ 0.0 $ 0.0
v3.25.3
FAIR VALUE MEASUREMENTS - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Sep. 06, 2025
Sep. 07, 2024
Sep. 06, 2025
Sep. 07, 2024
Feb. 22, 2025
Micro-Fulfillment Centers          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Impairment loss   $ 39.8      
Retail Stores          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Impairment loss $ 6.2   $ 8.4 $ 13.5  
Fair Value          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Total debt amount 7,778.7   7,778.7   $ 7,312.1
Carrying Value          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Total debt amount $ 7,777.1   $ 7,777.1   $ 7,452.4
v3.25.3
LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS - Narrative (Details) - USD ($)
6 Months Ended
Mar. 11, 2025
Sep. 06, 2025
Aug. 27, 2025
Feb. 22, 2025
Debt Instrument [Line Items]        
Unamortized debt discounts   $ 26,000,000.0   $ 28,600,000
Deferred financing costs   30,600,000   31,600,000
ABL Facility | Line of Credit        
Debt Instrument [Line Items]        
Outstanding balance on line of credit   325,000,000   0
Outstanding balance on letters of credit   $ 11,400,000   $ 27,400,000
Maximum borrowing capacity     $ 4,000,000,000  
ABL Facility | Line of Credit | Minimum        
Debt Instrument [Line Items]        
Basis spread on variable rate   1.25%    
ABL Facility | Line of Credit | Maximum        
Debt Instrument [Line Items]        
Basis spread on variable rate   1.50%    
Letter Of Credit Sub-Facility | Line of Credit        
Debt Instrument [Line Items]        
Deferred financing costs     11,900,000  
Maximum borrowing capacity   $ 1,500,000,000    
Capitalized financing costs     $ 1,400,000  
Senior Unsecured Notes, Maturity 2033 | Senior Notes        
Debt Instrument [Line Items]        
Face amount $ 600,000,000.0      
Stated interest rate percentage 6.25%      
Senior Unsecured Notes, Maturity 2026 | Senior Notes        
Debt Instrument [Line Items]        
Stated interest rate percentage 7.50%      
Repayments of senior debt $ 5,700,000      
Extinguishment of debt $ 600,000,000.0      
v3.25.3
LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS - Schedule of Long-term Debt (Details) - USD ($)
$ in Millions
Sep. 06, 2025
Feb. 22, 2025
Debt Instrument [Line Items]    
Finance lease obligations $ 406.0 $ 427.9
Total debt 8,126.5 7,820.1
Less current maturities (1,186.4) (57.6)
Long-term portion 6,940.1 7,762.5
Senior Unsecured Notes due 2026 to 2033, interest rate range of 3.25% to 6.50% | Senior Notes    
Debt Instrument [Line Items]    
Long-term debt, gross $ 6,517.9 6,517.0
Senior Unsecured Notes due 2026 to 2033, interest rate range of 3.25% to 6.50% | Senior Notes | Minimum    
Debt Instrument [Line Items]    
Stated interest rate percentage 3.25%  
Senior Unsecured Notes due 2026 to 2033, interest rate range of 3.25% to 6.50% | Senior Notes | Maximum    
Debt Instrument [Line Items]    
Stated interest rate percentage 6.50%  
New Albertsons L.P. Notes due 2026 to 2031, interest rate range of 6.52% to 8.70% | Notes Payable    
Debt Instrument [Line Items]    
Long-term debt, gross $ 487.0 484.6
New Albertsons L.P. Notes due 2026 to 2031, interest rate range of 6.52% to 8.70% | Notes Payable | Minimum    
Debt Instrument [Line Items]    
Stated interest rate percentage 6.52%  
New Albertsons L.P. Notes due 2026 to 2031, interest rate range of 6.52% to 8.70% | Notes Payable | Maximum    
Debt Instrument [Line Items]    
Stated interest rate percentage 8.70%  
Safeway Inc. Notes due 2027 to 2031, interest rate range of 7.25% to 7.45% | Notes Payable    
Debt Instrument [Line Items]    
Long-term debt, gross $ 376.2 375.9
Safeway Inc. Notes due 2027 to 2031, interest rate range of 7.25% to 7.45% | Notes Payable | Minimum    
Debt Instrument [Line Items]    
Stated interest rate percentage 7.25%  
Safeway Inc. Notes due 2027 to 2031, interest rate range of 7.25% to 7.45% | Notes Payable | Maximum    
Debt Instrument [Line Items]    
Stated interest rate percentage 7.45%  
ABL Facility | Line of Credit    
Debt Instrument [Line Items]    
Long-term debt, gross $ 325.0 0.0
Other financing obligations    
Debt Instrument [Line Items]    
Long-term debt, gross $ 14.4 $ 14.7
v3.25.3
EMPLOYEE BENEFIT PLANS - Schedule of Components of Net Pension and Post-Retirement Expense (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Sep. 06, 2025
Sep. 07, 2024
Sep. 06, 2025
Sep. 07, 2024
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]        
Settlement (income) loss $ (26.8)   $ (26.8)  
Pension        
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]        
Estimated return on plan assets (21.2) $ (21.1) (49.5) $ (49.2)
Service cost 3.8 3.9 8.7 9.0
Interest cost 18.1 19.3 42.3 45.2
Amortization of prior service cost 0.1 0.1 0.2 0.2
Amortization of net actuarial gain (0.7) (0.8) (1.6) (2.0)
Settlement (income) loss (26.8) 4.7 (26.8) 4.7
(Income) expense, net (26.7) 6.1 (26.7) 7.9
Other post-retirement benefits        
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]        
Estimated return on plan assets 0.0 0.0 0.0 0.0
Service cost 0.0 0.0 0.0 0.0
Interest cost 0.2 0.1 0.3 0.3
Amortization of prior service cost 0.0 0.0 0.0 0.0
Amortization of net actuarial gain (0.2) (0.2) (0.4) (0.4)
Settlement (income) loss 0.0 0.0 0.0 0.0
(Income) expense, net $ 0.0 $ (0.1) $ (0.1) $ (0.1)
v3.25.3
EMPLOYEE BENEFIT PLANS - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Sep. 06, 2025
Sep. 07, 2024
Sep. 06, 2025
Sep. 07, 2024
Retirement Benefits [Abstract]        
Contribution made to defined benefit plan $ 3.0 $ 24.4 $ 45.9 $ 37.1
Expected future employer contributions for remainder of the fiscal year 12.2   12.2  
Defined benefit plan, transferred 290.0   290.0  
Defined benefit pension obligation 295.0   295.0  
Settlement gain $ 26.8   $ 26.8  
v3.25.3
COMMITMENTS AND CONTINGENCIES AND OFF BALANCE SHEET ARRANGEMENTS (Details)
$ in Millions
6 Months Ended
Jul. 02, 2025
lawsuit
Jul. 30, 2024
lawsuit
Sep. 06, 2022
lawsuit
case
claim
Sep. 06, 2025
USD ($)
lawsuit
case
claim
Aug. 19, 2025
USD ($)
Dec. 10, 2024
USD ($)
Aug. 09, 2023
count
Apr. 18, 2023
case
Feb. 25, 2023
USD ($)
Merger Agreement                  
Loss Contingencies [Line Items]                  
Termination fee obligation | $           $ 600.0      
Qui Tam Lawsuits | Pending Litigation                  
Loss Contingencies [Line Items]                  
Number of lawsuits filed against the company | lawsuit       2          
Qui Tam Lawsuits | Pending Litigation | Minimum                  
Loss Contingencies [Line Items]                  
Loss contingency, amount of damages sought (in excess of) | $       $ 100.0          
United States ex rel. Schutte and Yarberry v. SuperValu, New Albertson's, Inc., et al. | Pending Litigation                  
Loss Contingencies [Line Items]                  
Number of lawsuits filed against the company | case               2  
Pharmacy Benefit Manager (PBM) Litigation | Pending Litigation                  
Loss Contingencies [Line Items]                  
Number of lawsuits filed against the company | count             17    
Consolidated Cases for Multidistrict Litigation                  
Loss Contingencies [Line Items]                  
Number of lawsuits filed against the company | claim     3 3          
Claims settled | case     15            
Liability for settlements | $                 $ 21.5
Consolidated Cases for Multidistrict Litigation | New Mexico Counties                  
Loss Contingencies [Line Items]                  
Additional claims | lawsuit     14            
Consolidated Cases for Multidistrict Litigation | Threatened Litigation                  
Loss Contingencies [Line Items]                  
Number of lawsuits filed against the company | case       2,000          
Additional claims | lawsuit 108 150              
Consolidated Cases for Multidistrict Litigation | Threatened Litigation | Blackfeet Tribe                  
Loss Contingencies [Line Items]                  
Number of new claims filed | lawsuit       81          
Consolidated Cases for Multidistrict Litigation | Threatened Litigation | Tarrant County (Texas), Town of Hull (Massachusetts) and Monterey County (California)                  
Loss Contingencies [Line Items]                  
Number of lawsuits filed against the company | claim       2          
State Of Washington Litigation | Pending Litigation                  
Loss Contingencies [Line Items]                  
Attorneys' fees and costs | $         $ 28.4        
Post-judgement interest accrual         12.00%        
v3.25.3
OTHER COMPREHENSIVE INCOME OR LOSS (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Sep. 06, 2025
Sep. 07, 2024
Sep. 06, 2025
Sep. 07, 2024
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance $ 3,224.3 $ 2,913.1 $ 3,385.9 $ 2,747.5
Other comprehensive income before reclassifications     11.7 3.7
Amounts reclassified from accumulated other comprehensive income     (28.6) 2.5
Tax benefit (expense)     4.4 (1.6)
Other comprehensive (loss) income (12.1) 5.9 (12.5) 4.6
Ending balance 3,079.5 3,020.3 3,079.5 3,020.3
Accumulated other comprehensive income        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance 94.3 86.7 94.7 88.0
Ending balance 82.2 92.6 82.2 92.6
Pension and Post-retirement benefit plans        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance     92.4 87.5
Other comprehensive income before reclassifications     9.6 0.0
Amounts reclassified from accumulated other comprehensive income     (28.6) 2.5
Tax benefit (expense)     4.9 (0.6)
Other comprehensive (loss) income     (14.1) 1.9
Ending balance 78.3 89.4 78.3 89.4
Other        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance     2.3 0.5
Other comprehensive income before reclassifications     2.1 3.7
Amounts reclassified from accumulated other comprehensive income     0.0 0.0
Tax benefit (expense)     (0.5) (1.0)
Other comprehensive (loss) income     1.6 2.7
Ending balance $ 3.9 $ 3.2 $ 3.9 $ 3.2
v3.25.3
SEGMENT INFORMATION - Narrative (Details)
6 Months Ended
Sep. 06, 2025
format
segment
Segment Reporting [Abstract]  
Number of reportable segments | segment 1
Number of store formats | format 1
v3.25.3
SEGMENT INFORMATION - Segment Reporting Information, by Segment (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Sep. 06, 2025
Sep. 07, 2024
Sep. 06, 2025
Sep. 07, 2024
Segment Reporting Information [Line Items]        
Net sales and other revenue $ 18,915.8 $ 18,551.5 $ 43,796.6 $ 42,816.9
Reconciliation to Income before income taxes:        
Depreciation and amortization     (1,007.4) (973.9)
Interest expense, net (105.3) (103.6) (247.1) (249.3)
Equity-based compensation expense     (52.4) (66.2)
(Loss) gain on property dispositions and impairment losses, net (4.4) (43.9) 27.5 (49.2)
LIFO expense (11.0) (4.8) (28.3) (19.4)
Income before income taxes 219.7 186.5 531.1 496.4
Reportable Segment        
Segment Reporting Information [Line Items]        
Net sales and other revenue 18,915.8 18,551.5 43,796.6 42,816.9
Retail segment expenses:        
Merchandise costs, including advertising, distribution and freight 13,395.0 13,077.5 31,015.9 30,164.0
Employee costs 2,746.7 2,715.5 6,406.9 6,265.6
Other segment expenses 1,595.8 1,546.5 3,676.4 3,581.7
Retail segment EBITDA 991.4 1,025.9 2,274.1 2,395.7
Reconciliation to Income before income taxes:        
Corporate adjustments (143.0) (125.3) (314.7) (311.2)
Depreciation and amortization (434.7) (421.9) (1,007.4) (973.9)
Interest expense, net (105.3) (103.6) (247.1) (249.3)
Business transformation (35.3) (20.5) (73.6) (37.8)
Equity-based compensation expense (18.7) (29.5) (52.4) (66.2)
(Loss) gain on property dispositions and impairment losses, net (4.4) (43.9) 27.5 (49.2)
LIFO expense (11.0) (4.8) (28.3) (19.4)
Merger-related costs (19.0) (67.4) (38.0) (159.7)
Certain legal and regulatory accruals and settlements, net (8.4) (8.7) (11.0) 0.2
Miscellaneous adjustments 8.1 (13.8) 2.0 (32.8)
Income before income taxes 219.7 186.5 531.1 496.4
Reportable Segment | Retail segment sales        
Segment Reporting Information [Line Items]        
Net sales and other revenue 18,728.9 18,365.4 43,373.3 42,407.0
Reportable Segment | Other revenue        
Segment Reporting Information [Line Items]        
Net sales and other revenue $ 186.9 $ 186.1 $ 423.3 $ 409.9
v3.25.3
NET INCOME PER CLASS A COMMON SHARE (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 4 Months Ended 6 Months Ended
Sep. 06, 2025
Sep. 07, 2024
Jun. 14, 2025
Jun. 15, 2024
Sep. 06, 2025
Sep. 07, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Net income $ 168.5 $ 145.5 $ 236.4 $ 240.7 $ 404.9 $ 386.2
Weighted average Class A common shares outstanding - Basic (in shares) 559.7 580.1     567.3 579.5
Weighted average Class A common shares outstanding - Diluted (in shares) 562.5 583.2     569.9 582.4
Basic net income per Class A common share (in dollars per share) $ 0.30 $ 0.25     $ 0.71 $ 0.67
Diluted net income per Class A common share (in dollars per share) $ 0.30 $ 0.25     $ 0.71 $ 0.66
Dilutive effect of restricted stock units and awards            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Dilutive effect of restricted stock units and awards (in shares) 2.8 3.1     2.6 2.9